electroCore to Present at Planet MicroCap Toronto 2026 powered by MicroCapClub
electroCore (Nasdaq: ECOR) will present at Planet MicroCap Toronto 2026 on October 28 at the Arcadian Court & Loft.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
electroCore (Nasdaq: ECOR) will present at Planet MicroCap Toronto 2026 on October 28 at the Arcadian Court & Loft. Co-CEO, President and CFO Joshua Lev will deliver the presentation at 9:30 am ET and host one-on-one investor meetings throughout the October 27–29 conference.
Details
Market Reaction – ECOR
On Oct 21, the day this news came out, the latest delayed price for ECOR is 2.87% above the previous close. The latest delayed price is $7.71.
Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ROCKAWAY, N.J., Oct. 21, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be presenting at Planet MicroCap Toronto 2026 Powered by MicroCapClub being held at the Arcadian Court & Loft. Joshua Lev, Co-CEO, President and CFO, will deliver a presentation and host one-on-one investor meetings throughout the conference.
Conference Details:
Dates: October 27-29
Company Presentation: Wednesday, October 28 at 9:30 am ET
Location: Arcadian Court & Loft, 401 Bay St., Simpson Tower, 8th Floor Toronto, ON, M5H 2Y4
Webcast: https://event.summitcast.com/view/iiVo9HYfz9sL9CC5m4Dgpv/N22s45azRsLw3U5aeUR5NF
If you would like to book one-on-one investor meetings with electroCore and attend Planet MicroCap Toronto 2026, please register at https://planetmicrocap.com.
About electroCore, Inc.
electroCore, Inc. is a bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company’s two leading prescription products, gammaCore® non-invasive vagus nerve stimulation (nVNS) and Quell® neurostimulator, treat chronic pain syndromes through non-invasive neuromodulation technology. Additionally, the company commercializes its handheld, and personal use Truvaga™ and TAC-STIM™ nVNS products utilizing bioelectronic technologies to promote general wellness and human performance.
For more information, visit www.electrocore.com.
Contact:
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com
